| 書目名稱 | Pharmacokinetic Challenges in Drug Discovery |
| 編輯 | O. Pelkonen,A. Baumann,A. Reichel |
| 視頻video | http://file.papertrans.cn/746/745577/745577.mp4 |
| 叢書名稱 | Ernst Schering Foundation Symposium Proceedings |
| 圖書封面 |  |
| 描述 | Despite increased spending on research and development, the number of new medicines marketed successfully continues to decline. The Pharmaceutical industry is therefore focussing on ways to reduce attrition by addressing frequent reasons for clinical drug failures very early in the drug discovery process. One of the biggest challenges is the pharmacokinetic (PK) optimisation of drug candidates tailored and predicted to have appropriate absorption, distribution, metabolism and excretion (ADME) characteristics in human. This book describes how traditional pbarmacokinetic approaches and methods are being re-invented‘ to meet specific needs dictated by the dynamics of the drug discovery process. The book gives an overview of state-of-the-art tools and their use in the decision-making process is discussed by a number of scientists from leading pharmaceutical companies. |
| 出版日期 | Conference proceedings 2002 |
| 關(guān)鍵詞 | Drug Metabolism; Pharmocokinetics; absorption; cytochrome P450; drug; drug development; drug discovery; dru |
| 版次 | 1 |
| doi | https://doi.org/10.1007/978-3-662-04383-7 |
| isbn_softcover | 978-3-662-04385-1 |
| isbn_ebook | 978-3-662-04383-7Series ISSN 0947-6075 |
| issn_series | 0947-6075 |
| copyright | Springer-Verlag Berlin Heidelberg 2002 |
|Archiver|手機版|小黑屋|
派博傳思國際
( 京公網(wǎng)安備110108008328)
GMT+8, 2025-10-18 19:11
發(fā)表于 2025-3-21 18:50:19
